Sequence requirements of ATF2 and CREB binding to the human T-cell leukemia virus type 1 LTR R region

Virology

Volumn 218, Issue 2, 1996, Pages 362-371

  Xu, Xiao ^b   Kang, Shin Heh ^b   Heidenreich, Olaf ^b   Brown, David A ^a,b   Nerenberg, Michael I ^b  

^a Nanogen Inc USA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; MUTATION; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0030013727     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0205     Document Type: Article

References (52)

1. Abdel-Hafiz, H. A., Heasley, L. E., Kyriakis, J. M., Avruch, J., Kroll, D. J., Johnson, G. L., and Hoeffler, J. P. (1992). Activating transcription factor-2 DNA-binding activity is stimulated by phosphorylation catalyzed by p42 and p54 microtubule-associated protein kinases. Mol. Endocrinol. 6, 2079-2089.
2. Abdel-Hafiz, H. A., Chen, C. Y., Marcell, T., Kroll, D. J., and Hoeffler, J. P. (1993). Structural determinants outside of the leucine zipper influence the interactions of CREB and ATF-2: Interaction of CREB with ATF-2 blocks E1a-ATF-2 complex formation. Oncogene 8, 1161-1171.
3. Baldwin, A., and Sharp, P. (1988). Two transcription factors, H2TF1 and NF-kB, interact with a single regulatory sequence in class I MHC promoter. Proc. Natl. Acad. Sci. USA 85, 723-727.
4. Baranger, M. A. et al. (1995). Nature 376, 606.
5. Chatton, B., Bocco, J., Carie, M., Hauss, C., Reimund, B., Goetz, J., and Kedinger, C. (1993). Transcriptional activation by the adenovirus larger E1a product is mediated by members of the cellular transcription factor ATF family which can directly associate with E1a. Mol. Cell. Biol. 13, 561-570.
6. Dasgupta, P., Redy, C. D., Saikumar, P., and Reddy, P. E. (1992). The cellular proto-oncogene product Myb acts as transcriptional activator of the long terminal repeat of human T-lymphotropic virus type 1. J. Virol. 66, 270-276.
7. Evangelista, A., Maroushek, S., Minnigan, H., Larson, A., Retel, E., Haase, A., Gonzalez-Dunia, D., McFarlin, D., Mingioli, E., Jacobson, S., Osame, M., and Shunro, M. (1990). Nucleotide sequence analysis of a provirus derived from an individual with tropical spastic paraparesis. Microbial Pathogen. 8, 259-278.
8. Franklin, A. A., Kubik, M. F., Uittenbogaard, M. N., Brauweiler, A., Utaisincharoen, P., Matthews, M. A., Dynan, W. S., Hoeffler, J. P., and Nyborg, J. K. (1993). Transcription by human T-cell leukemia virus TAX protein is mediated through enhanced binding of activating transcription factor-2 (ATF-2) and cAMP element-binding protein (CREB). J. Biol. Chem. 268, 21225-21231.
9. Furukawa, Y., Osame, M., Kubota, R., Tara, M., and Yoshida, M. (1995). Human T-cell leukemia virus type-1 (HTLV-1) tax is expressed at the same level in infected cells of HTLV-1-associated myelopathy or tropical spastic paraparesis patients as in asymptomatic carriers but at a lower level in adult T-cell leukemia cells. Blood 85, 1865-1870.
10. Gartenhaus, R. B., Wong-Staal, F., and Klotman, M. E. (1991). The promoter of human T-cell leukemia virus type-I is repressed by the immediate-early gene region of human cytomegalovirus in primary blood. Blood 78, 2956-2961.
11. Georgopoulos, K., Morgan, B. A., and Moore, D. D. (1992). Functionally distinct isoforms of the CRE-BP DNA-binding protein mediate activity of a T-cell-specific enhancer. Mol. Cell. Biol. 12, 747-757.
12. Gessain, A., Boeri, E., Yanagihara, R., Gallo, R. C., and Franchini, G. (1993). Complete nucleotide sequence of a highly divergent human T-cell leukemia (lymphotropic) virus type 1 (HTLV-1) variant from melanesia: Genetic and phylogenetic relationship to HTLV-1 strains from other geograghical regions. J. Virol. 67, 1015-1023.
13. Gessain, A., Barin, F., Vernant, J C., Gout, Q., Maurs, L., Calender, A., and de The, G. (1985). Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet 2, 407-410.
14. Gitlin, S. D., Dittmer, J., Reid, R. L., and Brady, J N. (1993). Frontier in Molecular Biology. In (B. Cullen, Ed.), pp. 159-192. Oxford Univ. Press, Oxford, England.
15. Gonzalez-Dunia, D., Chirinian-Syan, S., Brahic, M., and Ozden, S. (1992a). Functional analysis of two long terminal repeats from the HTLV-1 retroviruses. Gene 116, 151-158.
16. Gonzalez-Dunia, D., Grimber, G., Briand, P., Brahic, M., and Ozden, S. (1992b). Tissue expression pattern directed in transgenic mice by the LTRof an HTLV-1 provirus isolated from a case of tropical spastic paraparesis. Virology 187, 705-710.
17. Gupta, S., Campbell, D., Derijard, B., and Davis, R. J. (1995). Transcription factor ATF-2 regulation by the JNK signal transduction pathway. Science 267, 389-393.
18. Hai, T., and Curran, T. (1991). Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88, 3720-3724.
19. Hoeffler J. P., Raine, C. S., Mingioli, E. S., and McFarlin, D. E. (1992). Structure/function relationships of CREB/ATF proteins. J. Invest Dermatol. 98, 21S-28S.
20. Iino, T., Takeuchi, K., Ham, S. H., Siomi, H., Sabe, H., and Kobayashi, N. (1986). Structural analysis of p28 adult T-cell leukemia associated antigen. J. Gen. Virol. 67, 1373-1379.
21. Jacobson, S., Raine, C. S., Mingioli, E. S., and McFarlin, D. E. (1988). Isolation of an HTLV-1 like retrovirus from patients with tropic spastic paraparesis. Nature 331, 540-543.
22. Kadonaga, J. T., and Tjian, R. (1986). Affinity purification of sequence specific DNA binding proteins. Proc. Natl. Acad. Sci. USA 83, 5889-5893.
23. Kashanchi, F., Duvall, J. F., Lindholm, P. F., Radonovich, M. F., and Brady, J. N. (1993). Sequences downstream of the RNA initiation site regulate human T-cell lymphotropic virus type I basal gene expression. J. Virol. 67, 2894-2902.
24. Komurian, F., Pelloquin, F., and de The, G. (1991). In vitro genomic variability of human T-cell leukemia virus type 1 depends more geography than upon pathologies. J. Virol. 65, 3770-3778.
25. Liu, F. and Green, M. R. (1990). A specific member of the ATF transcription factor family can mediate transcription activation by adenovirus E1a protein. Cell 61, 1217-1224.
26. MacGregor, P. F., Abte, C., and Curran, T. (1990). Direct cloning of leucine zipper proteins: Jun binds cooperatively to the CRE with CRE-Bp1. Oncogene 5, 451-458.
27. Mahienx, R., and de The, G. (1995). The tax mutation at nucleatide 7959 of human T cell leukemia virus type 1 (HTLV-1) is not associated with tropical spastic paraparesis/HTLV-1 associated myelopathy but is linked to the cosmopolitan molecular genotype [letter]. J. Virol. 69, 5925-5927.
28. Morgan, I. M., and Birnie, G. D. (1992). The serum response element and an AP-1/ATF sequence immediately downstream co-operate in the regulation of c-fos transcription. Cell Proliferation 25, 205-215.
29. Mukhopadhyaya, R., and Reza Sadaie, M. (1993). Nucleotide sequence analysis of HTLV-1 isolated from cerebrospinal fluid of a patient with TSP/HAM: Comparison to other HTLV-1 isolates. AIDS Res. Hum. Retroviruses 9, 109-114.
30. Muro, A. F., Bernath, V. A., and Kornblihtt, A. R. (1992). Interaction of the-170 cyclic AM P response element with the adjacent CCAAT box in the human fibronectin gene promoter. J. Biol. Chem. 267, 12767-12774.
31. Nakamura, M., Ohtani, K., Hinuma, Y., and Sugamula, K. (1988). Functional mapping of the activity of the R region in the human T-cell leukemia virus type I long terminal repeat to increase gene expression. Virus Genes 2, 147-155.
32. Nyborg, J. K., and Dynan, W. S. (1990). Interaction of cellular proteins with the human T-cell leukemia virus type I transcriptional control region: purification of cellular proteins that bind the 21-base paire repeat elements. J. Biol. Chem. 265, 8230-8236.
33. Osame M., Janssen, R., Kubota, H., Nishitani, H., Igata, A., Nagataki, S., Mori, M., Goto, I., Shimabukuro, H., and Khabbaz, R. (1990). Nationwide survey of HTLV-1 associated myelopathy in Japan association with blood transfusion. Ann. Neurol. 28, 50-56.
34. Perini G., Wagner, S., and Green, M. R. (1995). Recongnition of bZIP proteins by the human T-cell leukemia virus transactivator. Tax. Nature 376, 602-605.
35. Poiesz, B. J., Ruscetti, F. W., Reitz, M. S., Kalyanaraman, V. S., and Gallo, R. C. (1981). Isolation of a new type C retrovirus (HTLV-1) in primary uncultured cells of a patient with Sezary T cell leukemia. Nature 249, 268-271.
36. Ratner, L., Philpott, T., and Trowbridge, D. B. (1991). Nucleotide sequence analysis of human T-lymphotropic virus type 1 of diverse geographical origins. AIDS Res. Hum. Retroviruses 7, 923-941.
37. Reddy, E. P., Mettus, R. V., DeFreitas, E., Wroblewska, Z, Cisco, M., and Koprowski, H. (1988). Molecular cloning of human T-cell lymphotrophic virus type 1-like proviral genome from the peripheral lymphocyte DNA of a patient with chronic neurologic disorders. Proc. Natl. Acad. Sci. USA 85, 3599-3603.
38. Renjifo, B., Borrero, I., and Essex, M. (1995). Tax mutations associated with tropical spastic paraparesis/human T-cell leukemia virus type 1-associated myelopathy. J. Virol. 69, 261-2626.
39. Rodland, K. D., Pribow, D., Lenormand, P., Chen, S. L., and Magun, B. E. (1993). Characterization of a unique enhancer element responsive to cyclic AMP and elevated calcium. Mol. Endocrinol. 7, 787-796.
40. Rossner, M. T. (1992). Review: Hepatitis B virus X-gene product: A promiscuous transcriptional activator. J. Med. Virol. 36, 101-117.
41. Saito, M., Furukawa, Y., Kubota, R., Usaku, K., Sonoda, S., Izumo, S., Osame, M., and Yoshida, M. (1995). Frequent mutation in pX region of HTLV-1 is observed in HM/TSP patients, but not specifically associated with the central nervous system lesions. J. NeuroVirology 1, 286-294.
42. Seiki, M., Hattori, S., and Yoshida, M. (1982). Human T-cell leukemia virus: Molecular cloning of the provirus DNA and unique terminal structure. Proc. Natl. Acad. Sci. USA 79, 6899-6902.
43. Seiki, M., Hattori, S., Hirayama, Y., and Yoshida, M. (1983). Human T-cell leukemia virus: Complete nucleotide sequence of the provirus DNA and the unique terminal structure. Proc. Natl. Acad. Sci. USA 80, 3618-3622.
44. Seiki, M., Hikikoshi, A., and Yoshida, M. (1990). The U5 sequence is a cis-acting repressive element for genomic RNA expression of human T cell leukemia virus type 1. Virology 176, 81-86.
45. Suzuki, T., Fujisawa, J., Toita, M., and Yoshida, M. (1993). The transactivator tax of human T-cell leukemia virus type I (HTLV-I) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer. Proc. Natl. Acad. Sci. USA 90, 610-614.
46. Takebe, Y., Seiki, M., Fujisawa, J. I., Hoy, P., Yokota, K., Arai, K. I., Yoshida, M., and Arai, N. (1988). SRa promoter: An efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 8, 466-472.
47. Tanimura, A., Teshima, H., Fujisawa, J., and Yoshida, M. (1993). A new regulatory element that augments the Tax-dependent enhancer of human T-cell leukemia virus type 1 and cloning of cDNAs encoding its binding proteins. J. Virol. 67, 5375-5382.
48. Vallejo, M., Penchuk, L., and Habener, J. F. (1992). Somatostatin gene upstream enhancer element activated by a protein complex consisting of CREB, lsl-1-like, and a-CBF-like transcription factors. J. Biol. Chem. 267, 12876-12884.
49. Vandamme, A. M., Liu, H. F., Goubau, P., and Desmyter, J. (1994). Primate T-lymophotropic virus type 1 LTR sequence variation and its phylogenetic analysis: Compatiblity with an African origin of PTLV-1. Virology 202, 212-223.
50. Wagner, S., and Green, M. R. (1993). HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 262, 395-399.
51. Xu, X, Brown, D. A., Kitajima, I., Bilakovics, J., Fey, L. W., and Nerenberg, M. I. (1994). Transcriptional suppression of the human T-cell leukemia virus type 1 long terminal repeat occurs by an unconventional interaction of a CREB factor with the R region. Mol. Cell. Biol. 14, 5371-5383.
52. Zhao T. M., Robinson, M. A., Sawasdikosol, S., Simpson, M., and Kindt, T. J. (1993). Variation in HTLV-1 sequences from rabbit cell lines with diverse in vivo effects. Virology 195, 271-274.